Kura Oncology increases inducement stock option plan by 750,000 shares to 3.25M total

Kura Oncology, Inc.

Board approved amendment to 2023 Inducement Option Plan, adding 750,000 shares for total of 3,250,000 shares.
Plan reserved exclusively for nonstatutory stock options to new employees as inducement material to hire.
Amendment approved without stockholder approval per Nasdaq Rule 5635(c)(4).
Plan administered by independent directors or independent compensation committee.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.